PD-L1 — Targeted Therapies, Trials & Pipeline

Programmed death-ligand 1 expression is a predictive biomarker for anti-PD-1/PD-L1 checkpoint blockade across many tumor types.

Approved drugs targeting PD-L1

Investigational pipeline agents

Landmark trials